Organisations that were awarded funding during Stage 1 can apply for a share of £15 million (including VAT) to develop vaccine candidates and technologies in line with UK Vaccine Network priorities.
Programme: Innovate UK
Award: Share of up to £15 million
Opens: 11th Jun 2018
Closes: 27th Jun 2018
This is a Small Business Research Initiative (SBRI) competition. The Department of Health and Social Care (DHSC) will invest up to £15 million to support the further development of vaccine:
The aim of this competition is to support projects looking to develop vaccines, vaccine platform technologies and manufacturing technologies. These must provide an effective, rapid response during future outbreaks of the following pathogens:
Your products must:
Innovate UK will support aspects of vaccine candidate development at the preclinical stage. These include, but are not limited to:
Process finalisation involves moving from engineering batches to GxP (good manufacturing and/or laboratory practice) activities (such as manufacturing and regulatory safety, pharmacology and toxicology studies). These will support the authorisation of future clinical trials.
Innovate UK are also interested in supporting early clinical development if the innovation has reached this stage from its stage one activities.
Your proposal must focus on:
To lead a project, you must have been awarded funding in the first vaccines for global epidemics preclinical competition, which opened on 17 October 2016. You can work alone or with others from business, the research base or the third sector as subcontractors.
Your application must assign at least 50% of the contract value directly and exclusively to research and development (R&D) services. R&D can cover solution exploration and design. It can also include prototyping and field-testing the product or service.
R&D does not include:
Total project costs can be up to £2 million, including VAT. It must start by 1 September 2018 and can last up to 2 years.
Innovate UK will not fund projects that cover: